Revenue
$45.13B
Gross Margin
+56.4%
Operating Margin
+18.2%
Net Margin
+13.9%
Income statement waterfall for Abbott Laboratories (ABT) — TTM through Q1 2026
Net income: $6.28B
Margin breakdown for Abbott Laboratories (ABT) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $45.13B | $45.13B |
| Cost of Revenue | −$19.69B | $25.45B |
| Gross Profit | $25.45B | $25.45B |
| Operating Expenses | −$17.24B | $8.20B |
| Operating Income | $8.20B | $8.20B |
| Other Income / Expense | −$65.00M | $8.14B |
| Pre-tax Income | $8.14B | $8.14B |
| Income Tax | −$1.86B | $6.28B |
| Net Income | $6.28B | $6.28B |
- Revenue$45.13B
- Cost of Revenue−$19.69B
- Gross Profit$25.45B
- Operating Expenses−$17.24B
- Operating Income$8.20B
- Other Income / Expense−$65.00M
- Pre-tax Income$8.14B
- Income Tax−$1.86B
- Net Income$6.28B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement